CAMP - cathelicidin antimicrobial peptide Gene

Also Known as LL37; CAP18; CRAMP; HSD26; CAP-18; FALL39; FALL-39

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 820

About CAMP

Cytogenetic location: 3p21.31 Genomic coordinates (GRCh38): 3:48,223,495-48,225,485 (from NCBI)

This gene has 2 transcripts (splice variants) and 249 orthologues. Restricted expression toward bone marrow (RPKM 591.5).

Summary

This gene encodes a member of an antimicrobial peptide family, characterized by a highly conserved N-terminal signal peptide containing a cathelin domain and a structurally variable cationic antimicrobial peptide, which is produced by extracellular proteolysis from the C-terminus. The protein plays an important role in innate immunity defense against viruses. In addition to its Antibacterial, Antifungal, and Antiviral activities, the encoded protein functions in cell chemotaxis, immune mediator induction, and inflammatory response regulation. [provided by RefSeq, Sep 2021]

CAMP Products (1)

mRNA	Protein	Name
NM_004345.5	NP_004336.4	cathelicidin antimicrobial peptide preproprotein

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables protein binding	IPI IPI: Inferred from physical interaction	31818937	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in amyloid fibril formation	EXP EXP: Inferred from Experiment	32753597	GOA
involved in amyloid fibril formation	IDA IDA: Inferred from direct assay	32753597	GOA
involved in antibacterial humoral response	IDA IDA: Inferred from direct assay	7529412	GOA
involved in antifungal humoral response	IDA IDA: Inferred from direct assay	14978112	GOA
involved in antimicrobial humoral immune response mediated by antimicrobial peptide	IDA IDA: Inferred from direct assay	7529412	GOA
involved in antimicrobial humoral immune response mediated by antimicrobial peptide	IMP IMP: Inferred from mutant phenotype	17012259	GOA
involved in chronic inflammatory response	IMP IMP: Inferred from mutant phenotype	9182550	GOA
involved in cytolysis	EXP EXP: Inferred from Experiment	9452503	GOA
involved in cytolysis by host of symbiont cells	IDA IDA: Inferred from direct assay	20421939	GOA
involved in defense response to Gram-negative bacterium	IDA IDA: Inferred from direct assay	7529412	GOA
involved in defense response to Gram-positive bacterium	IDA IDA: Inferred from direct assay	7529412	GOA
involved in defense response to Gram-positive bacterium	IMP IMP: Inferred from mutant phenotype	17012259	GOA
acts upstream of or within defense response to bacterium	IMP IMP: Inferred from mutant phenotype	21115716	GOA
involved in innate immune response	IDA IDA: Inferred from direct assay	7529412	GOA
involved in innate immune response	IMP IMP: Inferred from mutant phenotype	17012259	GOA
involved in innate immune response in mucosa	IDA IDA: Inferred from direct assay	12860195	GOA
acts upstream of or within killing by host of symbiont cells	IDA IDA: Inferred from direct assay	16177355	GOA
involved in killing by host of symbiont cells	IDA IDA: Inferred from direct assay	16020269	GOA
involved in modulation of process of another organism	IDA IDA: Inferred from direct assay	23537644	GOA
involved in neutrophil activation	IDA IDA: Inferred from direct assay	22879591	GOA
involved in positive regulation of interleukin-8 production	IMP IMP: Inferred from mutant phenotype	14978112	GOA
involved in response to yeast	IDA IDA: Inferred from direct assay	14978112	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in extracellular space	IDA IDA: Inferred from direct assay	12759353	GOA
located in specific granule	IDA IDA: Inferred from direct assay	12759353	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CAMP Protein Structure

Cathelicidins

CAP18_C

0
100
170 a.a.

Protein Preferred Names	Protein Names
cathelicidin antimicrobial peptide	18 kDa cationic antimicrobial protein

CAMP Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P82635	Cathelicidin Antibody (YA2380)	WB, IHC-P, IP	Human
HY-P82635A	Cathelicidin Antibody (YA2380)(PBS only)	WB, IHC-P, IP	Human
HY-P85074	Cathelicidin Antibody (YA4766)	ELISA	Species independent

Related Diseases

Diseases	Alias
Rosacea	Erythematotelangiectatic Rosacea Papulopustular Rosacea Phymatous Rosacea Acne Roscea Acne, Erythematosa Granulomatous Rosacea Ocular Rosacea Acne Rosacea Hypertrophic Rosacea
Cellulitis
Facial Dermatosis	Facial Dermatoses
Mycobacterium Marinum	Mycobacterium Marinum Infection Fish Tank Granuloma M. Marinum
Bacterial Infectious Disease	Bacterial Infections Bacterial Infection Nos Disease Caused By Bacteria Bacterial Disease Or Disorder
Severe Congenital Neutropenia 3	Kostmann Syndrome Infantile Agranulocytosis Kostmann Disease Scn3 Severe Congenital Neutropenia Type 3
Hidradenitis Suppurativa	Acne Inversa Suppurative Hidradenitis Acne Inversa, Familial Apocrinitis Hidradenitides, Suppurative Hidradenitis, Suppurative Suppurative Hidradenitides Inverse Acne
Hidradenitis	Hydradenitis
Cystic Fibrosis	Mucoviscidosis CF Pseudomonas Aeruginosa, Susceptibility To Chronic Infection By, In Cystic Fibrosis Pseudomonas Aeruginosa Chronic Infection By, In Cystic Fibrosis Cystic Fibrosis Lung Disease, Modifier Of Cystic Fibrosis Of Pancreas Fibrocystic Disease Of Pancreas Cf - [Cystic Fibrosis] Cystic Fibrosis Nos Fibrocystic Disease Fibrocystic Disease Of The Pancreas Mucoviscidosis Of Pancreas Nonproliferative Fibrocystic Disease Pancreatic Cystic Fibrosis
Dermatitis, Atopic	Atopic Dermatitis Atopic Eczema Dermatitis, Atopic, Susceptibility To, 1 Atod Eczema, Atopic Dermatitis, Atopic 1 Allergic Dermatitis Atopic Neurodermatitis Besnier'S Prurigo Dermatitis, Atopic, 1 Dermatitis Atopic Eczema Besnier Prurigo
Psoriasis
Necrotizing Fasciitis	Fasciitis, Necrotizing
Coffin-Lowry Syndrome	CLS Coffin Syndrome 1 Coffin Syndrome Intellectual Disability With Osteocartilaginous Abnormalities Dwarfism, Lean Spastic Type Lean Spastic Dwarfism Mental Retardation With Osteocartilaginous Abnormalities Coffin Lowry Syndrome
Skin Disease	Skin Diseases Genodermatosis Abnormality Of The Skin Skin Diseases, Genetic Skin And Subcutaneous Tissue Disease Dermatologic Disorders
Disease By Infectious Agent	Infectious Disease Infectious Diseases
Papillon-Lefevre Syndrome	Papillon-Lefevre Disease Papillon-Lefèvre Syndrome PLS Keratosis Palmoplantaris With Periodontopathia PALS Papillon Lefevre Syndrome Keratosis Palmoplantar-Periodontopathy Syndrome Papillon-Lefvre Syndrome Hyperkeratosis Palmoplantaris With Periodontosis Keratoris Palmoplantaris With Periodontopathia Keratosis Palmoplantar - Periodontopathy Palmar-Plantar Hyperkeratosis And Concomitant Periodontal Destruction Palmoplantar Keratoderma With Periodontosis Palsy
Toxic Shock Syndrome	Septic Shock Toxic Shock Tss Shock, Septic Staphylococcal Toxic Shock Syndrome Tss - [Toxic Shock Syndrome]
Eczema Herpeticum	Herpes Simplex Dermatitis Herpes Simplex Eyelid Dermatitis Kaposi Varicelliform Eruption Herpes Simplex Dermatitis Of Eyelid Herpes Simplex Virus Dermatitis Herpes Simplex Virus Eyelid Dermatitis
Denture Stomatitis	Stomatitis, Denture Denture Sore Mouth
Autoimmune Disease Of Skin And Connective Tissue
Impetigo
Polycystic Kidney Disease	Polycystic Kidney Diseases Pkd Polycystic Renal Disease Kidney Disease, Polycystic Polycystic Kidney, Autosomal Dominant
Sebaceous Gland Disease	Sebaceous Gland Anomaly Sebaceous Gland Diseases
Vaginal Disease	Vaginal Diseases
Shigellosis	Dysentery, Bacillary Bacillary Dysentery Shigella Boydii Infectious Disease Shigella Flexneri Infectious Disease Shigella Gastroenteritis Shigella Sonnei Infectious Disease Shigella Infections
Mycobacterium Tuberculosis 1	Tuberculosis Tuberculoma Tuberculosis, Susceptibility To Mycobacterium Tuberculosis, Susceptibility To, 1 Mtbs1 TB
Contact Dermatitis	Contact Dermatitis/Eczema Contact Eczema Dermatitis Venenata Dermatitis, Venenata Dermatitis Contact Dermatitis, Contact
Chancroid	Ulcus Molle, Skin Chancroids Bubo Due To Haemophilus Ducreyi Soft Chancre Ulcus Molle
Vaginitis	Infective Vaginitis Inflammation Of Vagina Colpitis Vaginal Inflammation Vaginitis Nos
Fallopian Tube Disease	Fallopian Tube Diseases
Tinea Pedis	Athlete'S Foot Dermatophytosis Of Foot Ringworm Of Foot Moccasin Foot
Dermatophytosis	Tinea Dermatophytosis, Unspecified Ringworm Infections Due To Species Of Epidermophyton, Microsporum And Trichophyton Cutaneous Mycosis Dermal Mycosis Superficial Mycosis, Unspecified Fungus Infection Of Skin Skin Mycosis Dermatitis Fungoid Fungal Dermatitis Fungal Dermatosis Mycotic Infection Of Skin
Allergic Contact Dermatitis	Dermatitis, Allergic Contact Contact Dermatitis, Allergic Dermatitis Allergic Contact Allergic Contact Eczema Acd - [Allergic Contact Dermatitis] Allergic Contact Dermatitis, Unspecified Cause Allergic Dermatitis Allergic Eczema Allergy Dermatitis Allergy Eczema Allergic Contact Eczema Due To Clothing Or Footwear Perfume Allergic Contact Dermatitis Allergic Contact Dermatitis Due To Cosmetics Allergic Contact Eczema Due To Cosmetics Or Fragrances Allergic Contact Eczema Due To Dental Materials Allergic Contact Eczema Due To Food Flavours Or Additives Allergic Contact Eczema Due To Hairdressing Products Allergic Contact Eczema Due To Metals Or Metal Salts Allergic Contact Eczema Due To Proteins Allergic Contact Eczema Due To Plastics Or Resin Systems Allergic Contact Eczema Due To Preservatives Or Biocides Allergic Contact Eczema Due To Rubber Chemicals Rubber Dermatitis Allergic Contact Eczema Due To Systemic Medicaments Allergic Contact Eczema Due To Topical Medicaments Allergic Contact Dermatitis Due To Drugs In Contact With Skin
Endocardium Disease
Colorectal Cancer	Colon Cancer Colorectal Carcinoma Colon Carcinoma Colorectal Cancer, Susceptibility To Carcinoma Of Colon CRC Colorectal Cancer With Chromosomal Instability, Somatic Colon Cancer, Somatic Colon Cancer, Susceptibility To Colonic Neoplasms Colorectal Neoplasms Colorectal Cancer, Somatic Colon Cancer, Advanced, Somatic Colonic Carcinoma Colorectal Carcinomas Colon Cancers Colorectal Cancers Cancer, Colorectal, Somatic Cancer, Colon Cancer, Colorectal, Susceptibility To Colorectal Neoplasm Colonic Neoplasm Malignant Tumor Of Colon
Urethritis	Nonspecific Urethritis Non-Gonococcal Urethritis Nongonococcal Urethritis
Gingival Disease	Gingival Diseases Gum Disease Gingival Disorder Gingivitis And Periodontal Diseases
Asthma	Chronic Obstructive Asthma Asthma, Diminished Response To Antileukotriene Treatment In Bronchial Hyperreactivity Asthma, Susceptibility To Asthma, Bronchial Asthma, Protection Against Asthma, Nocturnal, Susceptibility To Nocturnal Asthma Asthma-Related Traits Asthma-Related Traits, Susceptibility To Asthma, Nocturnal Chronic Obstructive Asthma With Acute Exacerbation Chronic Obstructive Asthma With Status Asthmaticus Exercise Induced Asthma Exercise-Induced Asthma Bronchial Asthma Asthma, Exercise-Induced Idiosyncratic Asthma Unspecified Asthma With Acute Exacerbation Asthma, Unspecified, With Stated Status Asthmaticus Status Asthmaticus Nos Acute Severe Asthma Acute Severe Bronchial Asthma Status Asthma Status Post Asthmaticus
Telangiectasis	Telangiectasia
Urinary Tract Infection	Urinary Tract Infections Uti Urinary Tract Infection Nos Uti - [Urinary Tract Infection] Uti Nos - [Urinary Tract Infection Nos] Urosepsis Nos E Coli Uti E Coli Urinary Tract Infection Escherichia Coli Uti
Severe Congenital Neutropenia	Congenital Neutropenia Neutropenia, Severe Congenital Congenital Agranulocytosis Infantile Genetic Agranulocytosis Kostmann Disease Kostmann'S Agranulocytosis Kostmann'S Syndrome Severe Infantile Genetic Neutropenia
Scleredema Adultorum	Scleredema Buschke'S Scleredema Scleredema Adultorum Of Buschke Scleredema Diabeticorum Scleredema Diabeticorum Of Buschke Buschke Scleredema
Integumentary System Disease
Inflammatory Bowel Disease	Inflammatory Bowel Diseases Bowel Disease, Inflammatory
Primary Bacterial Infectious Disease
Polycystic Kidney Disease 4 With Or Without Polycystic Liver Disease	Autosomal Recessive Polycystic Kidney Disease Arpkd Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney And Hepatic Disease 1 Pkhd1 PKD4 Polycystic Kidney Disease 4 With Or Without Hepatic Disease Polycystic Kidney Disease, Infantile, Type I Polycystic Kidney Disease, Infantile Type Polycystic Kidney, Autosomal Recessive Pkd3, Formerly Polycystic Kidney Disease 4, With Or Without Hepatic Disease Arpkd/Chf Ar-Pkd Polycystic Kidney Disease 4, With Or Without Polycystic Liver Disease Infantile Polycystic Kidney Disease Type I Pkd3 Kidney, Polycystic, Disease, Type 4, With/Without Hepatic Disease Polycystic Kidney Disease 3, Autosomal Dominant
Acute Promyelocytic Leukemia	Leukemia, Acute Promyelocytic Acute Myeloblastic Leukemia Type 3 Aml M3 APL Leukemia, Acute Promyelocytic, Somatic Aml With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Apml Acute Myeloblastic Leukemia 3 Acute Myeloid Leukemia With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Acute Myeloblastic Leukaemia Type 3 Acute Myeloid Leukaemia M3 Acute Myeloid Leukemia M3 Acute Promyelocytic Leukaemia M3 Anll Myeloid Leukemia, Acute, M3 Leukemia Promyelocytic Acute Leukemia, Promyelocytic, Acute Leukemia, Acute, Promyelocytic

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (50)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0764	Bucladesine sodium	Activator	99.84%	Yes
HY-13749	Sitagliptin	Inhibitor	99.94%	Yes
HY-Y0682	Ethylenediaminetetraacetic acid		98.29%	Unkown
HY-15498	Rimegepant	Antagonist	99.99%	Unkown
HY-P0036	Octreotide		99.96%	Unkown
HY-14773	Mirabegron	Agonist	99.81%	Yes
HY-14302	Salmeterol	Agonist	99.69%	Yes
HY-B0377	Famotidine		99.85%	Yes
HY-13749A	Sitagliptin phosphate	Inhibitor	99.88%	Yes
HY-B0764A	Bucladesine hemicalcium		98.58%	Yes
HY-119708	Ensifentrine	Inhibitor	99.36%	Unkown
HY-108742	Abaloparatide	Activator	99.82%	Unkown
HY-12366	Ubrogepant	Antagonist	99.90%	Unkown
HY-14300A	Vilanterol trifenatate	Agonist	99.82%	Unkown
HY-B0735A	Fenoldopam mesylate	Agonist	99.94%	Unkown
HY-17592	Bithionol	Inhibitor	99.32%	Unkown
HY-B0679	Lubiprostone		99.09%	Yes
HY-17034B	Medetomidine hydrochloride	Agonist	99.94%	Unkown
HY-13749B	Sitagliptin phosphate monohydrate	Inhibitor	99.83%	Yes
HY-17453	Salmeterol xinafoate	Agonist	99.88%	Yes
HY-B1898	Metadoxine		99.88%	Yes
HY-14300	Vilanterol	Agonist	99.30%	Unkown
HY-108742A	Abaloparatide TFA	Activator	98.80%	Unkown
HY-17034	Medetomidine	Agonist	99.97%	Unkown
HY-B1481	Isoetharine mesylate	Agonist	99.05%	Unkown
HY-B0531	Triflusal		99.56%	Unkown
HY-106539	Colesevelam hydrochloride		98.00%	Unkown
HY-B1505	Acefylline		99.52%	Unkown
HY-B1639	Enoximone	Inhibitor	99.91%	Unkown
HY-128932	Cefminox sodium		99.83%	Unkown
HY-156131	Loperamide	Agonist	99.85%	Unkown
HY-B0327	Irsogladine		99.88%	Unkown
HY-B1009	Ethylenediaminetetraacetic acid trisodium salt		98.0%	Unkown
HY-B1209	Etofylline	Inhibitor	99.72%	Unkown
HY-B0813	Treprostinil diethanolamine	Agonist	99.44%	Yes
HY-13749AR	Sitagliptin phosphate (Standard)	Inhibitor	99.82%	Unkown
HY-B1428	2-Ethoxybenzamide		99.72%	Unkown
HY-B0764R	Bucladesine sodium (Standard)	Activator	99.81%	Unkown
HY-B1481A	Isoetharine	Agonist	/	Unkown
HY-114948	Rimiterol	Agonist	/	Unkown
HY-13749E	Sitagliptin hydrochloride	Inhibitor	/	Unkown
HY-17457	Levalbuterol hemitartrate		98.71%	Yes
HY-B0764B	Bucladesine		/	Unkown
HY-P0036B	Octreotide pamoate		/	Unkown
HY-P3445	Anrikefon	Agonist	/	Unkown
HY-12366R	Ubrogepant (Standard)	Antagonist	/	Unkown
HY-13749R	Sitagliptin (Standard)	Inhibitor	/	Unkown
HY-B0735	Fenoldopam	Agonist	/	Unkown
HY-B0735AR	Fenoldopam mesylate (Standard)	Agonist	/	Unkown
HY-B1428R	2-Ethoxybenzamide (Standard)		/	Unkown

Clinical Phase

Bioactive Molecules (47)

Cat. No.	Product Name	Effect	Purity	Phase
HY-W127774	EDTA hydrate sodium		97.0%	Phase 4
HY-116755	Tiropramide	Inhibitor	/	Phase 4
HY-P3366	Ecnoglutide	Agonist	99.93%	Phase 3
HY-19929	Tanimilast		99.71%	Phase 3
HY-50906	LY404039	Agonist	98.0%	Phase 3
HY-106358	Andolast free base	Inhibitor	98.37%	Phase 3
HY-119486A	(Rac)-Tavapadon	Agonist	99.49%	Phase 3
HY-16635	Setipiprant	Antagonist	98.23%	Phase 3
HY-173178	LNS8801	Agonist	/	Phase 3
HY-130786	Denbufylline	Inhibitor	99.92%	Phase 3
HY-105101	Osutidine	Antagonist	/	Phase 3
HY-16900	Rolipram	Inhibitor	99.87%	Phase 2
HY-B1511A	Cyclic AMP sodium		99.97%	Phase 2
HY-12472	Balipodect	Inhibitor	99.47%	Phase 2
HY-14550	TP-10	Inhibitor	99.95%	Phase 2
HY-153660	Bivamelagon	Agonist	99.50%	Phase 2
HY-12887	Piclamilast	Inhibitor	99.74%	Phase 2
HY-12525	LGD-6972	Antagonist	98.0%	Phase 2
HY-14899	Taprenepag	Agonist	98.79%	Phase 2
HY-100936	Etazolate hydrochloride		98.00%	Phase 2
HY-107046	UK-432097	Agonist	98.9%	Phase 2
HY-19867A	Burixafor hydrobromide	Antagonist	99.70%	Phase 2
HY-16642A	LY2828360	Agonist	99.50%	Phase 2
HY-14973	Vidupiprant	Antagonist	98.31%	Phase 2
HY-109139	Taminadenant	Antagonist	99.84%	Phase 2
HY-101189	JNJ-39758979	Antagonist	98.75%	Phase 2
HY-19436	Solabegron	Agonist	99.89%	Phase 2
HY-169792	HPG1860		99.9%	Phase 2
HY-128656	LML134	Agonist	99.43%	Phase 2
HY-106303	YT 146	Agonist	99.72%	Phase 2
HY-106137	Tofimilast	Inhibitor	/	Phase 2
HY-14869	Revamilast	Inhibitor	/	Phase 2
HY-178780	MKP10241	Agonist	98.06%	Phase 2
HY-19755	S-5751	Antagonist	/	Phase 2
HY-19867	Burixafor	Antagonist	/	Phase 2
HY-120547	UCB-11056		/	Phase 2
HY-136942	DS1	Agonist	/	Phase 2
HY-167201	2ccPA	Inhibitor	/	Phase 2
HY-18978	GR79236	Agonist	99.89%	Phase 1
HY-147017	GSK2556286	Inhibitor	99.70%	Phase 1
HY-14340	WAY-181187	Agonist	98.83%	Phase 1
HY-P10031	SAR441255	Agonist	99.84%	Phase 1
HY-123534	CYT-1010	Agonist	99.28%	Phase 1
HY-19946	Eptapirone	Agonist	99.91%	Phase 1
HY-124371	Amentoflavone hexaacetate		/	Phase 1
HY-19946A	Eptapirone fumarate	Agonist	/	Phase 1
HY-113402B	Gamma-glutamylcysteine ammonium		/	Phase 1

Pre-clinical Phase

Bioactive Molecules (677)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-15371	Forskolin		99.92%	Unkown
HY-12306	8-Bromo-cAMP sodium salt		99.91%	Unkown
HY-B1511	Cyclic AMP		99.95%	Yes
HY-12306A	8-Bromo-cAMP		99.48%	Unkown
HY-100927	Ro 20-1724	Inhibitor	99.98%	Unkown
HY-P0221	PACAP (1-38), human, ovine, rat	Inducer	99.99%	Unkown
HY-100403	Ro 67-7476	Agonist	99.69%	Unkown
HY-113402	Gamma-glutamylcysteine		98.53%	Unkown
HY-P10138	human GIP(3-30), amide	Antagonist	99.76%	Unkown
HY-121835	GLP-1R agonist 2	Agonist	99.57%	Unkown
HY-149164	BTB09089	Agonist	99.39%	Unkown
HY-P1237	C-Type Natriuretic Peptide (CNP) (1-22), human	Inhibitor	99.84%	Unkown
HY-103254	ML221		98.45%	Unkown
HY-W040329	2'-Deoxyadenosine		99.97%	Unkown
HY-103193	NKH477	Activator	99.86%	Unkown
HY-P1471	Adrenomedullin (AM) (22-52), human	Antagonist	99.61%	Unkown
HY-W140439	1-Oleoyl-sn-glycero-3-phosphocholine		99.58%	Unkown
HY-124696	PU139	Inhibitor	99.51%	Unkown
HY-16558	Butein		99.64%	Unkown
HY-122197	ML339	Antagonist	99.88%	Unkown
HY-P1291	PKI 14-22 amide,myristoylated	Inhibitor	98.96%	Unkown
HY-W012980	Isovaleric acid	Activator	≥98.0%	Unkown
HY-111673	8-CPT-Cyclic AMP sodium		99.92%	Unkown
HY-10301	MK-3207	Antagonist	99.60%	Unkown
HY-100530D	Rp-cAMPS sodium salt	Antagonist	99.69%	Unkown
HY-107543	8-pCPT-2′-O-Me-cAMP sodium	Activator	99.81%	Unkown
HY-P4860	Adropin (34-76) (human, mouse, rat)		98.23%	Unkown
HY-P10138A	human GIP(3-30), amide TFA	Antagonist	96.90%	Unkown
HY-P3419	PAMP-12 (unmodified)		99.40%	Unkown
HY-N2118	Bilobetin	Activator	99.71%	Unkown
HY-N6727	Gliotoxin		99.51%	Unkown
HY-125791	cis-Epoxysuccinic acid	Agonist	98.0%	Unkown
HY-P0221C	PACAP (1-38) free acid		99.94%	Unkown
HY-Y0682A	Ethylenediaminetetraacetic acid disodium dihydrate		99.9%	Unkown
HY-P6292A	KS-133 TFA	Antagonist	98.95%	Unkown
HY-B1511R	Cyclic AMP (Standard)		99.89%	Unkown
HY-B0392	(S)-(+)-Rolipram		99.96%	Unkown
HY-162734	BRD5075	Activator	98.72%	Unkown
HY-117656	ESI-05	Inhibitor	99.78%	Unkown
HY-133529	PA-8		97.00%	Unkown
HY-103194	KH7	Inhibitor	99.0%	Unkown
HY-P0222	PKI(5-24)	Inhibitor	99.99%	Unkown
HY-P1291A	PKI 14-22 amide,myristoylated TFA	Inhibitor	99.79%	Unkown
HY-P1852	TIP 39, Tuberoinfundibular Neuropeptide		99.84%	Unkown
HY-128358	MR-L2	Activator	98.63%	Unkown
HY-160734	Aleniglipron	Agonist	99.88%	Unkown
HY-P1023	VIP(6-28)(human, rat, porcine, bovine)	Antagonist	98.09%	Unkown
HY-P2847	Urocortin II, mouse	Agonist	99.94%	Unkown
HY-108539	CE3F4	Inhibitor	98.85%	Unkown
HY-112612A	RTI-13951-33 hydrochloride		98.56%	Unkown
HY-P0097A	Nonapeptide-1 acetate salt	Antagonist	95.58%	Unkown
HY-153967	BLU0588	Inhibitor	97.63%	Unkown
HY-P1290A	PKA Inhibitor Fragment (6-22) amide TFA	Inhibitor	99.77%	Unkown
HY-121615	α-Phellandrene	Activator	85.70%	Unkown
HY-P1298A	Sauvagine TFA	Agonist	99.96%	Unkown
HY-129658A	TT-OAD2	Agonist	99.59%	Unkown
HY-124151	Adenosine-2'-monophosphate	Activator	99.91%	Unkown
HY-135542	NBI-27914	Antagonist	99.94%	Unkown
HY-N0113	Hordenine	Inhibitor	99.88%	Unkown
HY-P0248	Kemptide		99.56%	Unkown
HY-P2878	Phosphodiesterase I		/	Unkown
HY-113402A	Gamma-glutamylcysteine TFA		96.68%	Unkown
HY-124717	YC-001		99.43%	Unkown
HY-18740A	Trequinsin hydrochloride	Inhibitor	99.86%	Unkown
HY-W250160	PDRN		90.20%	Unkown
HY-103565	AMN082	Agonist	99.73%	Unkown
HY-103431	A68930 hydrochloride	Agonist	98.71%	Unkown
HY-N0126	Xanthone	Inhibitor	99.97%	Unkown
HY-P1845	PACAP-38 (31-38), human, mouse, rat		98.93%	Unkown
HY-110036	GW-405833		98.91%	Unkown
HY-111385	UNC9994 hydrochloride		99.50%	Unkown
HY-136172	ESI-08	Antagonist	98.74%	Unkown
HY-175232	GL64	Inhibitor	98.80%	Unkown
HY-N3945	Glaucine		99.57%	Unkown
HY-P2917	Glycerol kinase, microorganism	Inhibitor	98.00%	Unkown
HY-P4127A	M65 TFA	Inhibitor	99.98%	Unkown
HY-W011683	2'-Deoxyadenosine monohydrate		99.89%	Unkown
HY-147395	GPR52 agonist-1	Agonist	99.21%	Unkown
HY-P10927	BRP		99.62%	Unkown
HY-117958	HJC0197	Inhibitor	99.62%	Unkown
HY-108618	BC11-38	Inhibitor	99.42%	Unkown
HY-143312	V-0219	Modulator	99.90%	Unkown
HY-N2038	3,5,6,7,8,3',4'-Heptemthoxyflavone	Inhibitor	99.86%	Unkown
HY-110218	CW 008	Agonist	98.52%	Unkown
HY-B1511S	Cyclic AMP-13C5		97.45%	Unkown
HY-N0910	Notoginsenoside Ft1		99.49%	Unkown
HY-10797	CJ-42794	Antagonist	98.96%	Unkown
HY-N1860	3-O-Methylquercetin	Inhibitor	99.98%	Unkown
HY-P1237A	C-Type Natriuretic Peptide (CNP) (1-22), human TFA		99.07%	Unkown
HY-100984	HA-100	Inhibitor	99.87%	Unkown
HY-108626	ML154	Antagonist	99.59%	Unkown
HY-119168	LP-471756	Antagonist	99.53%	Unkown
HY-124571	ZQ-16	Agonist	99.0%	Unkown
HY-147319	RTI-7470-44	Antagonist	99.85%	Unkown
HY-15478	WZ811	Antagonist	99.80%	Unkown
HY-P0172A	ATI-2341 TFA	Agonist	98.08%	Unkown
HY-P4823	pTH (1-37) (human)	Activator	99.91%	Unkown
HY-101572	MHP	Activator	98.57%	Unkown
HY-103302	SUN B8155	Agonist	99.89%	Unkown
HY-135490	Reproterol		98.94%	Unkown
HY-108539A	(R)-CE3F4	Inhibitor	99.3%	Unkown
HY-102076	0990CL		≥98.0%	Unkown
HY-131900	Protein kinase inhibitor H-7	Inhibitor	99.96%	Unkown
HY-136637	NPD-001	Inhibitor	98.11%	Unkown
HY-P0097	Nonapeptide-1	Antagonist	98.74%	Unkown
HY-P1913A	Calcitonin Gene Related Peptide II (rat) TFA	Activator	99.89%	Unkown
HY-111082	ISAM-140	Inhibitor	99.13%	Unkown
HY-123335A	L-796778 acetate	Agonist	98.00%	Unkown
HY-161106	OX04528	Agonist	98.45%	Unkown
HY-18286	NCGC00229600	Antagonist	99.67%	Unkown
HY-P1595	CREBtide	Substrate	98.33%	Unkown
HY-100530C	Sp-cAMPS sodium salt		99.45%	Unkown
HY-103547	L-168049	Antagonist	99.94%	Unkown
HY-107580	GPR109 receptor agonist-1	Agonist	99.94%	Unkown
HY-110206	AM6545	Antagonist	99.32%	Unkown
HY-129421	PA-9		99.73%	Unkown
HY-N0688	Linderane		98.61%	Unkown
HY-P10365	VPM-p15	Agonist	98.25%	Unkown
HY-P1106A	K41498 TFA	Antagonist	98.71%	Unkown
HY-100013C	2-PCCA hydrochloride		99.61%	Unkown
HY-103322	6-Bnz-cAMP sodium salt		98.5%	Unkown
HY-110036A	GW405833 hydrochloride		99.59%	Unkown
HY-163996	DD202-114		99.27%	Unkown
HY-P1065	Apelin-36(rat, mouse)		98.59%	Unkown
HY-Y0682B	Ethylenediaminetetraacetic acid tetrasodium	Inhibitor	98.0%	Unkown
HY-128879A	VP3.15 dihydrobromide	Inhibitor	98.0%	Unkown
HY-100656	Desmethyl cariprazine	Antagonist	98.08%	Unkown
HY-103180	2'-MeCCPA	Agonist	99.80%	Unkown
HY-103186	MRS-1706	Antagonist	98.07%	Unkown
HY-110003	Arachidonylcyclopropylamide	Agonist	99.9%	Unkown
HY-116818	Crebinostat	Inhibitor	98.83%	Unkown
HY-167856A	RTI-122 dihydrochloride	Agonist	99.36%	Unkown
HY-N2168	Pinoresinol 4-O-β-D-glucopyranoside	Inhibitor	99.89%	Unkown
HY-P1845A	PACAP-38 (31-38), human, mouse, rat TFA		99.30%	Unkown
HY-P5189A	His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA		99.94%	Unkown
HY-101232	Tiotidine	Antagonist	99.28%	Unkown
HY-117829	UNC9994		98.06%	Unkown
HY-121793	Roemerine	Inhibitor	99.89%	Unkown
HY-139178	KVA-D-88	Inhibitor	99.81%	Unkown
HY-176293	EP2 receptor antagonist-3		99.08%	Unkown
HY-P11237	Enicepatide	Agonist	98.16%	Unkown
HY-P1296	Urocortin, rat	Agonist	99.23%	Unkown
HY-105118A	Zaldaride maleate	Antagonist	99.7%	Unkown
HY-111527	PPZ2		99.92%	Unkown
HY-116530	9-Cyclopentyladenine monomethanesulfonate	Inhibitor	99.95%	Unkown
HY-116874	SKF 83822	Agonist	98.01%	Unkown
HY-131763	2'-O-MB-cAMP sodium		99.95%	Unkown
HY-134266	8-Bromo-AMP		98.78%	Unkown
HY-137640C	Rp-8-Br-cAMPS sodium	Inhibitor	99.9%	Unkown
HY-50158	Glucagon receptor antagonist-2	Antagonist	99.23%	Unkown
HY-P10716	Exendin-P5	Activator	96.32%	Unkown
HY-P5275	Tripeptide-41		99.30%	Unkown
HY-113402R	Gamma-glutamylcysteine (Standard)		98.14%	Unkown
HY-P10031A	SAR441255 TFA	Agonist	99.93%	Unkown
HY-P10336	Serpinin	Agonist	98.74%	Unkown
HY-RS16241	Camp Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-111896	7-Methoxyrosmanol	Inhibitor	99.28%	Unkown
HY-118941	BAY 73-1449	Antagonist	98.40%	Unkown
HY-120511	KNT-127	Agonist	99.11%	Unkown
HY-135119	Salmeterol-d3	Inhibitor	98.04%	Unkown
HY-13749AS	Sitagliptin-d4 phosphate	Inhibitor	99.48%	Unkown
HY-143312A	V-0219 hydrochloride	Modulator	99.39%	Unkown
HY-162735	BRD5080	Activator	99.44%	Unkown
HY-163671	PW0729		99.55%	Unkown
HY-P10728	B7-33		99.31%	Unkown
HY-P1106	K41498	Antagonist	99.66%	Unkown
HY-P1290	PKA Inhibitor Fragment (6-22) amide	Inhibitor	98.00%	Unkown
HY-N8593	Undecane		99.66%	Unkown
HY-13749S1	Sitagliptin-d4 hydrochloride	Inhibitor	99.36%	Unkown
HY-123820	LY3020371 hydrochloride	Antagonist	99.18%	Unkown
HY-107544	8-pCPT-2'-O-Me-cAMP-AM	Activator	99.7%	Unkown
HY-112465	H-8 dihydrochloride	Inhibitor	99.19%	Unkown
HY-121541	CB-25		98.84%	Unkown
HY-134598A	653-47 hydrochloride	Inhibitor	99.42%	Unkown
HY-148867	UCM-1306	Modulator	99.49%	Unkown
HY-175231	ST171	Agonist	99.34%	Unkown
HY-178234	LY237	Agonist	99.96%	Unkown
HY-19026	Siguazodan	Inhibitor	99.06%	Unkown
HY-P1250	RFRP-3(human)	Agonist	99.43%	Unkown
HY-P2197	ELA-11(human)		99.54%	Unkown
HY-P2285	AC 253	Antagonist	98.54%	Unkown
HY-100656AS	Desmethyl cariprazine-d8		99.93%	Unkown
HY-123650	FSBA hydrochloride		99.06%	Unkown
HY-131768	2'-O-Succinyl-cAMP		99.0%	Unkown
HY-N0113B	Hordenine hydrochloride	Inhibitor	99.82%	Unkown
HY-N11141	(R)-Octopamine	Agonist	95.22%	Unkown
HY-P0172	ATI-2341	Agonist	99.64%	Unkown
HY-N0113S	Hordenine-d6	Inhibitor	98.03%	Unkown
HY-100530B	Sp-cAMPS		/	Unkown
HY-103178	MRE3008F20	Antagonist	99.70%	Unkown
HY-103565A	AMN082 free base	Agonist	98.37%	Unkown
HY-106045	Imazodan	Inhibitor	99.38%	Unkown
HY-108623	Atizoram	Inhibitor	96.3%	Unkown
HY-108991	T-0509	Agonist	98.01%	Unkown
HY-110040	L759633	Agonist	99.9%	Unkown
HY-132240	SF-22	Antagonist	99.49%	Unkown
HY-132993	Hcyb1	Inhibitor	98.20%	Unkown
HY-137640A	Sp-8-Br-cAMPS sodium	Agonist	99.9%	Unkown
HY-153213A	Org 274178-0	Antagonist	99.40%	Unkown
HY-161405	NPFF1-R antagonist 1	Inhibitor	99.38%	Unkown
HY-170788	PDE7A-IN-1	Inhibitor	99.83%	Unkown
HY-182774	YU241279	Inhibitor	99.58%	Unkown
HY-185107	CTR/AMYR modulator-2	Agonist	/	Unkown
HY-N0126R	Xanthone (Standard)	Inhibitor	99.99%	Unkown
HY-P10927A	BRP TFA		/	Unkown
HY-P2249	ELA-21 (human)		99.97%	Unkown
HY-P4665	Ac-c[Cys-Glu-His-d-Phe-Arg-Trp-d-Cys]-Pro-Pro-Lys-Asp-NH2	Antagonist	98.14%	Unkown
HY-P6292	KS-133		98.75%	Unkown
HY-W010178	4-Methyloctanoic acid	Inhibitor	99.85%	Unkown
HY-W040329S1	2'-Deoxyadenosine-13C10		99.0%	Unkown
HY-125782	15(R)-15-Methyl prostaglandin D2		98.0%	Unkown
HY-137370	2-Hexynyl-5′-N-ethylcarboxamidoadenosine		99.39%	Unkown
HY-162394	Vasopressin V2 receptor antagonist 2	Antagonist	99.81%	Unkown
HY-16900R	Rolipram (Standard)	Inhibitor	99.24%	Unkown
HY-P10256A	Kiss2 peptide acetate	Activator	/	Unkown
HY-112612	RTI-13951-33		/	Unkown
HY-100013	2-PCCA	Agonist	/	Unkown
HY-100013B1	(1S,2S)-2-PCCA hydrochloride	Control	99.65%	Unkown
HY-100530	Rp-cAMPS triethylammonium salt	Antagonist	99.9%	Unkown
HY-101317	TAN-67 dihydrobromide	Agonist	99.20%	Unkown
HY-103172	8-Aminoadenine	Inhibitor	98.34%	Unkown
HY-103369	PG01	Activator	98.04%	Unkown
HY-106739	Motapizone	Inhibitor	95.0%	Unkown
HY-108258	PSN 375963	Agonist	99.95%	Unkown
HY-108621	RS-25344 hydrochloride	Inhibitor	99.93%	Unkown
HY-113689	GAT211	Agonist	99.96%	Unkown
HY-114727	PDE7-IN-4		98.55%	Unkown
HY-115553	DETQ	Agonist	/	Unkown
HY-120246	GS-5759		99.21%	Unkown
HY-120826	A2AAR/hMAO-B-IN-1	Inhibitor	99.0%	Unkown
HY-120994	Rp-8-CPT-cAMPS sodium	Antagonist	≥99.0%	Unkown
HY-123335	L-796778	Agonist	98.00%	Unkown
HY-123396	8-Chloro-cAMP	Modulator	99.84%	Unkown
HY-125382A	L-797591 hydrochloride	Agonist	99.81%	Unkown
HY-125957	A-3 hydrochloride	Inhibitor	99.45%	Unkown
HY-131032	KI-7	Agonist	99.16%	Unkown
HY-134254	8-AHA-cAMP		99.0%	Unkown
HY-136974	9-Deoxyforskolin		98.16%	Unkown
HY-141495	(Rac)-Razpipadon	Agonist	97.09%	Unkown
HY-14296A	PF-610355 (hydrochloride)	Agonist	/	Unkown
HY-151392	LPA5 antagonist 2	Antagonist	99.62%	Unkown
HY-156772	GPR88 agonist 2	Agonist	99.57%	Unkown
HY-160921	Capeserod	Agonist	98.66%	Unkown
HY-167856	RTI-122	Agonist	/	Unkown
HY-182638	CPL500036		/	Unkown
HY-401913	endo CNTinh-03	Inhibitor	99.96%	Unkown
HY-N12378	β-Patchoulene		96.88%	Unkown
HY-N6901	Luteolin 7-sulfate		≥95.0%	Unkown
HY-N8092	Kushenol B	Inhibitor	96%	Unkown
HY-P1597	Malantide		98.04%	Unkown
HY-P2197A	ELA-11(human) TFA	Chemical	99.03%	Unkown
HY-P2867	Phosphodiesterase II, Bovine Spleen		/	Unkown
HY-P3570	Adipokinetic hormone II (Locusta migratoria)		99.58%	Unkown
HY-P3572	Adipokinetic hormone I (Locusta migratoria)		99.88%	Unkown
HY-P4890A	Relaxin H3 (human) TFA		/	Unkown
HY-P99004	hMC1R agonist 1	Antagonist	/	Unkown
HY-Q40876	BBT	Modulator	99.71%	Unkown
HY-RS01870	CAMP Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-113402AR	Gamma-glutamylcysteine TFA (Standard)		95.17%	Unkown
HY-113513	5-HEPE		98.01%	Unkown
HY-121837	β2AR-IN-15	Antagonist	98.84%	Unkown
HY-134395	6-MB-cAMP		/	Unkown
HY-137308	15(R)-Prostaglandin D2		99.9%	Unkown
HY-171591	SIK2-IN-4	Inhibitor	99.06%	Unkown
HY-43934	Tiropramide hydrochloride	Inhibitor	/	Unkown
HY-N2452	Cochinchinenin C	Agonist	/	Unkown
HY-W105700	Ethylenediaminetetraacetic acid sodium hydrate		98.0%	Unkown
HY-130304	8-Isoprostaglandin E2	Activator	98.31%	Unkown
HY-15371G	Forskolin (GMP)		/	Unkown
HY-P4863	Biotinyl-Amylin (human)	Agonist	98.75%	Unkown
HY-W010178R	4-Methyloctanoic acid (Standard)	Inhibitor	/	Unkown
HY-106358A	Andolast	Inhibitor	/	Unkown
HY-119236	CP-432		/	Unkown
HY-123534A	CYT-1010 hydrochloride	Agonist	/	Unkown
HY-126250	NPD-1335	Inhibitor	98.10%	Unkown
HY-165456	AGN-190851		/	Unkown
HY-184213	INCB106385	Antagonist	/	Unkown
HY-100530A	Rp-cAMPS	Antagonist	/	Unkown
HY-100984A	HA-100 hydrochloride	Inhibitor	/	Unkown
HY-101189B	JNJ-39758979 dihydrochloride	Antagonist	/	Unkown
HY-101826A	ER21355 hydrochloride	Inhibitor	/	Unkown
HY-101863	CB-6673567	Inhibitor	/	Unkown
HY-105118	Zaldaride	Inhibitor	/	Unkown
HY-105482	BMY 20844	Inhibitor	/	Unkown
HY-105517	MDL 27032	Inhibitor	/	Unkown
HY-105912	ONO 1082		/	Unkown
HY-105931	Lixazinone	Inhibitor	/	Unkown
HY-106045A	Imazodan hydrochloride	Inhibitor	/	Unkown
HY-106893	Pimilprost	Agonist	/	Unkown
HY-107506	Ro 67-4853	Agonist	99.90%	Unkown
HY-107612	GPBAR-A	Agonist	/	Unkown
HY-108258A	PSN 375963 hydrochloride	Agonist	/	Unkown
HY-108648A	2-MeSADP	Agonist	/	Unkown
HY-110005	Sp-cAMPS triethylamine		/	Unkown
HY-110070	DL-AP4 sodium	Agonist	/	Unkown
HY-110107	GW438014A	Antagonist	99.98%	Unkown
HY-110161	sst2 Receptor agonist-1	Agonist	/	Unkown
HY-11032	SM-350300		/	Unkown
HY-110366	WAY-181187 oxalate	Agonist	/	Unkown
HY-112363	Aloisine A		/	Unkown
HY-112631	OPC 33540	Inhibitor	/	Unkown
HY-113243	1-Oleoyl lysophosphatidylcholine	Activator	/	Unkown
HY-113781	Ractopamine	Agonist	/	Unkown
HY-113822	Lixazinone hydrogensulfate	Inhibitor	/	Unkown
HY-113918	SW-106	Antagonist	/	Unkown
HY-114052	NVP-ABE171	Inhibitor	/	Unkown
HY-114539	L-750667 triHydrochloride	Antagonist	99.39%	Unkown
HY-114990	EMD 57439	Inhibitor	/	Unkown
HY-115643	AZ13581837		/	Unkown
HY-115769	1,2-Didecanoylglycerol	Activator	/	Unkown
HY-116119	BDF 9148	Activator	/	Unkown
HY-116295	MRS2690		/	Unkown
HY-116295A	MRS2690 disodium		/	Unkown
HY-116312	8-pCPT-2′-O-Me-cAMP	Activator	/	Unkown
HY-116445	UNC9975	Agonist	/	Unkown
HY-116540	L 858051	Activator	/	Unkown
HY-116540A	L 858051 dihydrochloride	Activator	/	Unkown
HY-116755S2	Tiropramide-d5 oxalate	Inhibitor	/	Unkown
HY-116806	AF-2785	Inhibitor	/	Unkown
HY-117181	UK-1745	Inhibitor	/	Unkown
HY-117694	MK-8825	Antagonist	/	Unkown
HY-117715	CK-3197	Inhibitor	/	Unkown
HY-118175	RG 14921	Inhibitor	/	Unkown
HY-119114	E-2508 free base	Antagonist	/	Unkown
HY-119247	NBI 30545	Antagonist	/	Unkown
HY-119708A	Ensifentrine tosylate	Inhibitor	/	Unkown
HY-120093	GAT100		/	Unkown
HY-120195	PF-04677490	Inhibitor	/	Unkown
HY-120684	PDE10-IN-6	Inhibitor	/	Unkown
HY-120687	A68930	Agonist	/	Unkown
HY-120879	PF2562	Agonist	/	Unkown
HY-120994A	Rp-8-CPT-cAMPS	Antagonist	/	Unkown
HY-120994B	Sp-8-CPT-cAMPS	Activator	/	Unkown
HY-121041	GEBR-7b		/	Unkown
HY-121249	Capeserod hydrochloride	Agonist	/	Unkown
HY-122189	Akuammine		/	Unkown
HY-122622	PF-04471141 hydrochloride	Inhibitor	/	Unkown
HY-123008	Reproterol hydrochloride		/	Unkown
HY-123782	(Rac)-UK-414495	Inhibitor	/	Unkown
HY-124381	ML10375	Modulator	/	Unkown
HY-124635	BC-54		/	Unkown
HY-125020	NCGC00135472	Activator	/	Unkown
HY-12520	SKF 38393		/	Unkown
HY-12525B	LGD 6972 ammonium	Antagonist	/	Unkown
HY-125646	YH18968	Activator	/	Unkown
HY-126754	Archangelicin	Inhibitor	/	Unkown
HY-12880	HA-100 dihydrochloride	Inhibitor	/	Unkown
HY-129089	(-)-MDO-NPA	Ligand	/	Unkown
HY-129210	KMUP-4		/	Unkown
HY-129658	TT-OAD2 free base	Agonist	/	Unkown
HY-129980A	NPC-15437		/	Unkown
HY-130176	UFP-512		/	Unkown
HY-130629	VHC-7	Agonist	/	Unkown
HY-131772	2-AHA-cAMP		/	Unkown
HY-133151	CXCR6 antagonist 1	Antagonist	/	Unkown
HY-134263	8-Br-cAMP-AM	Agonist	/	Unkown
HY-134264	8-Br-2'-O-Me-cAMP	Activator	/	Unkown
HY-134283	8-Benzylthio-cAMP	Activator	/	Unkown
HY-134298	8-CPT-6-Phe-cAMP	Activator	/	Unkown
HY-134321	8-Azido-cAMP		/	Unkown
HY-134340	8-pMeOPT-2'-O-Me-cAMP	Activator	/	Unkown
HY-134598	653-47	Inhibitor	/	Unkown
HY-135079	Lerimazoline	Agonist	/	Unkown
HY-136501	MRS2395	Antagonist	/	Unkown
HY-13749S2	Sitagliptin-d4	Inhibitor	/	Unkown
HY-137638	Sp-5,6-DCl-cBIMPS	Activator	/	Unkown
HY-137638A	Sp-5,6-DCl-cBIMPS sodium	Activator	/	Unkown
HY-137640B	Rp-8-Br-cAMPS	Inhibitor	/	Unkown
HY-139486	AM-8123	Agonist	99.89%	Unkown
HY-14132	BMS-665053	Antagonist	/	Unkown
HY-142972	19(S)-HETE	Agonist	/	Unkown
HY-14300AS	Vilanterol-d4 trifenatate	Agonist	/	Unkown
HY-14300D	Vilanterol acetate	Agonist	/	Unkown
HY-14302S1	Salmeterol-d5	Agonist	/	Unkown
HY-14326	L-750667	Ligand	99.26%	Unkown
HY-14341	E-6837	Ligand	/	Unkown
HY-144705	GAT564	Modulator	/	Unkown
HY-145156	CHU-128	Agonist	/	Unkown
HY-14773S	(Rac)-Mirabegron-d5	Agonist	/	Unkown
HY-147751	APJ receptor agonist 6		/	Unkown
HY-147946	PDE1-IN-4	Inhibitor	/	Unkown
HY-148032	5-Benzyloxytryptamine	Agonist	/	Unkown
HY-148827	GEM-231	Inhibitor	/	Unkown
HY-148827A	GEM-231 sodium	Inhibitor	/	Unkown
HY-149168	PF-4211	Agonist	/	Unkown
HY-149247	Antipsychotic agent-2		/	Unkown
HY-149933	AM841	Activator	/	Unkown
HY-150056	CB1R Allosteric modulator 3		98.05%	Unkown
HY-150057	CB1R Allosteric modulator 4	Modulator	/	Unkown
HY-150073	DS01080522	Inhibitor	/	Unkown
HY-153542	AP-C6	Inhibitor	/	Unkown
HY-153660A	Bivamelagon hydrochloride	Agonist	/	Unkown
HY-153660S	Bivamelagon-d8	Agonist	/	Unkown
HY-15498S	Rimegepant-d4	Antagonist	/	Unkown
HY-156434	PDE11A4-IN-1	Inhibitor	/	Unkown
HY-156536	RXFP1 receptor agonist-1		/	Unkown
HY-156537	RXFP1 receptor agonist-2		/	Unkown
HY-156538	RXFP1 receptor agonist-3		/	Unkown
HY-156539	RXFP1 receptor agonist-4		/	Unkown
HY-156540	RXFP1 receptor agonist-5		/	Unkown
HY-156541	RXFP1 receptor agonist-6		/	Unkown
HY-156542	RXFP1 receptor agonist-7		/	Unkown
HY-156543	RXFP1 receptor agonist-8		/	Unkown
HY-158179	A3AR agonist 3	Agonist	/	Unkown
HY-158180	A3AR agonist 4	Agonist	/	Unkown
HY-158181	A3AR agonist 5	Agonist	/	Unkown
HY-159917	PPL agonist-1		/	Unkown
HY-159920	PSB-22269	Antagonist	/	Unkown
HY-159942	5-HT7R antagonist 3		/	Unkown
HY-160864	Torbafylline	Inhibitor	/	Unkown
HY-161107	OX04529	Agonist	/	Unkown
HY-161506	PDE1-IN-7	Inhibitor	/	Unkown
HY-161817	TGR5 agonist 5	Agonist	/	Unkown
HY-162401	AZ7976	Agonist	/	Unkown
HY-162581	FCPR16	Inhibitor	/	Unkown
HY-162787	Adenosine receptor antagonist 5	Antagonist	/	Unkown
HY-163345	5-HT7R antagonist 2	Antagonist	/	Unkown
HY-163530	GPR41 modulator 1	Modulator	/	Unkown
HY-163651	(R)-Vorbipiprant	Antagonist	/	Unkown
HY-165436	Toborinone	Inhibitor	/	Unkown
HY-168481	GLP-1R agonist 27	Agonist	/	Unkown
HY-168558	PDE4B/D-IN-4	Inhibitor	/	Unkown
HY-16900G	Rolipram (GMP)	Inhibitor	/	Unkown
HY-169833	BL 6341A	Antagonist	/	Unkown
HY-169963	PDE1-IN-8	Inhibitor	/	Unkown
HY-170431	SAL-0010042	Inhibitor	/	Unkown
HY-170908	Pellotine	Antagonist	/	Unkown
HY-170948	A2AR modulator-1	Modulator	/	Unkown
HY-171069	FFA2 agonist-1	Agonist	/	Unkown
HY-171302	GLP-1R/GIPR agonist-2	Agonist	/	Unkown
HY-171590	SIK2-IN-3	Inhibitor	/	Unkown
HY-171850	GLP-1R modulator-1	Agonist	/	Unkown
HY-171851	GLP-1R agonist 32	Agonist	/	Unkown
HY-171909	Glycerophosphoinositol 4-phosphate		/	Unkown
HY-171909A	Glycerophosphoinositol 4-phosphate disodium		/	Unkown
HY-173044	5-HT1AR/5-HT6R ligand-1		/	Unkown
HY-173290	PDE4D inhibitor 1	Inhibitor	/	Unkown
HY-173360	PDE10A-IN-5	Inhibitor	/	Unkown
HY-173479	GLP-1R agonist 30	Agonist	/	Unkown
HY-17453S	Salmeterol-d3 xinafoate	Agonist	/	Unkown
HY-17453S1	Salmeterol-13C6 xinafoate	Agonist	/	Unkown
HY-174986	CGRP antagonist 7	Antagonist	/	Unkown
HY-175001	D1/D5 Receptor agonist-1	Inhibitor	/	Unkown
HY-175195	Adenosine receptor antagonist 6		/	Unkown
HY-175483S	TrkB activator-1	Activator	/	Unkown
HY-175486	KOR agonist 6	Agonist	/	Unkown
HY-175666	ISAM-CG557		/	Unkown
HY-175982	AURKA-IN-3	Inhibitor	/	Unkown
HY-176493	GLP-1R agonist 33	Agonist	/	Unkown
HY-176504	Adenosine receptor agonist 2	Agonist	/	Unkown
HY-176520	PDE4-IN-29	Inhibitor	/	Unkown
HY-177122	Raxlaprazine etomoxil	Modulator	/	Unkown
HY-177493A	SSTR3 agonist-1 TFA	Agonist	/	Unkown
HY-178103	D1R antagonist 2	Antagonist	/	Unkown
HY-178203	AM12814	Agonist	/	Unkown
HY-178478	PDE1-IN-11	Inhibitor	99.24%	Unkown
HY-178783	MRS8454	Modulator	/	Unkown
HY-178982	Apelin agonist 2	Agonist	/	Unkown
HY-179240	UNC9815	Modulator	/	Unkown
HY-179241	UNC10062	Modulator	/	Unkown
HY-179248	Adenosine receptor antagonist 7		/	Unkown
HY-179407	LT-104A	Inhibitor	/	Unkown
HY-179471	PSB-17365	Agonist	/	Unkown
HY-179504	PDE4B-IN-6	Inhibitor	/	Unkown
HY-179645	Phosphodiesterase-IN-5		/	Unkown
HY-179724	PZ-1657	Inhibitor	/	Unkown
HY-179724A	PZ-1657 hydrochloride	Inhibitor	/	Unkown
HY-179725	PZ-1129	Ligand	/	Unkown
HY-179728	Amylin agonist 1	Agonist	/	Unkown
HY-180142	XYDC2050	Antagonist	/	Unkown
HY-180198	UCM1400		/	Unkown
HY-180300	N6-Ethoxycarbonyl-cAMP		/	Unkown
HY-180372	CSP-2503	Agonist	/	Unkown
HY-181047	FMJ-01-042	Agonist	/	Unkown
HY-181049	FMJ-01-054	Antagonist	/	Unkown
HY-181088	PDE3/4-IN-4	Inhibitor	/	Unkown
HY-181571	PDE4-IN-33	Inhibitor	/	Unkown
HY-181589	PDE11A4-IN-2	Inhibitor	/	Unkown
HY-181738	GPR17 agonist 2		/	Unkown
HY-181822	BMS-986331		99.81%	Unkown
HY-181956	MPAM-15	Modulator	/	Unkown
HY-182011	GPR6 inverse agonist 2	Agonist	/	Unkown
HY-182414	NCO-650 free base	Inhibitor	/	Unkown
HY-182415	RX-RA-69	Inhibitor	/	Unkown
HY-182452	U 84569	Inhibitor	/	Unkown
HY-182453	RM1490	Modulator	/	Unkown
HY-182473	AL-6556	Agonist	/	Unkown
HY-182502	GLP-1R-agonist-43	Agonist	/	Unkown
HY-182503	GP515	Inhibitor	/	Unkown
HY-182580	HBK001		/	Unkown
HY-182640	SM-11044	Agonist	/	Unkown
HY-182645	CRF1 receptor antagonist-2	Antagonist	/	Unkown
HY-182705	Org 214444-0		/	Unkown
HY-182714	N 0840	Antagonist	/	Unkown
HY-182850	UCUF-965	Modulator	/	Unkown
HY-182905	SSTR5/TGR5-modulator-1	Modulator	/	Unkown
HY-182909	CXCR4-antagonist-11	Antagonist	/	Unkown
HY-183657A	GPR3 inverse agonist-1 TFA		/	Unkown
HY-183693	GLP-1 receptor agonist 21	Agonist	/	Unkown
HY-183694	GLP-1 receptor agonist 22	Agonist	/	Unkown
HY-183734	Obuprazine		/	Unkown
HY-184192	R-185	Agonist	/	Unkown
HY-184208	MCL-524	Agonist	/	Unkown
HY-184476	SLL-022CCP	Agonist	/	Unkown
HY-184490	BPR1M492	Agonist	/	Unkown
HY-184680	β2AR agonist 6		/	Unkown
HY-184681	β2AR agonist 7		/	Unkown
HY-184728	Antifungal agent-169	Inhibitor	/	Unkown
HY-184925	GPR43 agonist 1		/	Unkown
HY-185289	Methoxyfenoterol		/	Unkown
HY-185643	PF-04475270	Agonist	/	Unkown
HY-186020	L-4-Aminoarabinose-bactoprenyl phosphate		/	Unkown
HY-186104	AMYR/CTR agonist 1	Agonist	/	Unkown
HY-186200	PTHR1 antagonist 1	Antagonist	/	Unkown
HY-186214	PDE4-IN-36	Inhibitor	/	Unkown
HY-186252	GPR133 agonist 1	Agonist	/	Unkown
HY-187342	KOR modulator-1	Modulator	/	Unkown
HY-19436A	Solabegron hydrochloride	Agonist	/	Unkown
HY-69172	RS-25344	Inhibitor	/	Unkown
HY-B0377G	Famotidine (GMP)		/	Unkown
HY-B0377S	Famotidine-13C,d3		/	Unkown
HY-B0531S	Triflusal-d3		/	Unkown
HY-B1505G	Acefylline (GMP)		/	Unkown
HY-B1511G	Cyclic AMP (GMP)		/	Unkown
HY-D1187	2-Aza-ε-cAMP		/	Unkown
HY-D1187A	2-Aza-ε-cAMP sodium		/	Unkown
HY-E71643	3',5'-Cyclic-AMP phosphodiesterase		/	Unkown
HY-N0113A	Hordenine sulfate		/	Unkown
HY-N0113R	Hordenine (Standard)	Inhibitor	/	Unkown
HY-N1189	DL-Syringaresinol diacetate		/	Unkown
HY-N13132	Hellicoside	Inhibitor	/	Unkown
HY-N14663	Griseolic acid C	Inhibitor	/	Unkown
HY-N19773	(S)-Mansonone E		/	Unkown
HY-N2658	5,7-Diacetoxy-8-methoxyflavone	Inhibitor	98.04%	Unkown
HY-N3324	Mangostanol	Inhibitor	/	Unkown
HY-N3464	Isopedicin	Inhibitor	/	Unkown
HY-N3550	Catalponol		/	Unkown
HY-N3773	Dodoviscin A	Inhibitor	/	Unkown
HY-N6256	Ilexsaponin B2	Inhibitor	98.47%	Unkown
HY-N8593S	Undecane-d24		/	Unkown
HY-P0036A	Octreotide dihydrochloride		/	Unkown
HY-P0165B	Taspoglutide acetate	Agonist	/	Unkown
HY-P0221A	PACAP (1-38), human, ovine, rat TFA	Inducer	/	Unkown
HY-P0222A	PKI(5-24) TFA	Inhibitor	/	Unkown
HY-P0252B	α-MSH free acid	Agonist	/	Unkown
HY-P10047	PKItide	Inhibitor	/	Unkown
HY-P10256	Kiss2 peptide	Activator	/	Unkown
HY-P1065A	Apelin-36(rat, mouse) TFA		/	Unkown
HY-P10924	Roseltide rT1	Inhibitor	/	Unkown
HY-P11246	A13:B7-24-GG	Agonist	/	Unkown
HY-P11275	TC4	Agonist	/	Unkown
HY-P11279	TC2	Agonist	/	Unkown
HY-P11586	San45	Agonist	/	Unkown
HY-P11818	GIPR/GLP-1R/GCGR agonist-1		/	Unkown
HY-P11880	LY3324954	Agonist	/	Unkown
HY-P11881	IUB288		/	Unkown
HY-P1250A	RFRP-3(human) TFA	Agonist	/	Unkown
HY-P1296A	Urocortin, rat TFA	Agonist	/	Unkown
HY-P1298	Sauvagine	Agonist	/	Unkown
HY-P1325	BWX 46	Agonist	/	Unkown
HY-P1471A	Adrenomedullin (AM) (22-52), human TFA	Antagonist	/	Unkown
HY-P1595A	CREBtide TFA	Substrate	98.72%	Unkown
HY-P1597A	Malantide TFA		/	Unkown
HY-P1913	Calcitonin Gene Related Peptide II (rat)	Activator	/	Unkown
HY-P3419A	PAMP-12 (unmodified) TFA	Agonist	/	Unkown
HY-P3544	Lys-[Hyp3]-Bradykinin	Agonist	/	Unkown
HY-P3770	Phosphate acceptor peptide	Inhibitor	/	Unkown
HY-P3786	H-Arg-Gly-Tyr-Ala-Leu-Gly-OH	Inhibitor	/	Unkown
HY-P3930	PKI (5-24),amide	Inhibitor	/	Unkown
HY-P4497	Prolylserine		/	Unkown
HY-P4817	Human PTH-(1-31)		/	Unkown
HY-P4890	Relaxin H3 (human)		/	Unkown
HY-P5757	(D-Trp32)-Neuropeptide Y (porcine)	Agonist	/	Unkown
HY-P5950	ACTH (6-24) (human)	Inhibitor	/	Unkown
HY-RS02596	CHAMP1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W011683S	2'-Deoxyadenosine monohydrate-1′-13C		/	Unkown
HY-W011683S1	2'-Deoxyadenosine monohydrate-2′-13C		/	Unkown
HY-W011683S2	2'-Deoxyadenosine monohydrate-3′-13C		/	Unkown
HY-W011683S3	2'-Deoxyadenosine monohydrate-5′-13C		/	Unkown
HY-W011683S6	2'-Deoxyadenosine monohydrate-13C10,15N5 hydrate		99.7%	Unkown
HY-W040329S	2'-Deoxyadenosine-13C10,15N5		/	Unkown
HY-W040329S3	2'-Deoxyadenosine-15N5,d13		/	Unkown
HY-W087947	EDTA dihydrate tripotassium		97.0%	Unkown
HY-W127485	cis-9,10-Methyleneoctadecanoic Acid		/	Unkown
HY-W349178	Medorinone	Inhibitor	/	Unkown
HY-W664041	Noncatechol agonist-1		/	Unkown
HY-W673613	ADX68692	Inhibitor	/	Unkown
HY-W707517	Famotidine-d4		/	Unkown
HY-W745905	2'-Deoxyadenosine-15N1		/	Unkown
HY-W746031	WAY-181187 hydrochloride	Agonist	/	Unkown
HY-W777002	Famotidine-13C3		/	Unkown
HY-100543R	Zenidolol (Standard)		/	Unkown
HY-101987A	(Rac)-BW 245C	Agonist	/	Unkown
HY-106830	Pelrinone	Inhibitor	/	Unkown
HY-110107A	GW438014A free base	Antagonist	/	Unkown
HY-117064	NY-0173	Antagonist	/	Unkown
HY-119333	NNC 11-1607	Agonist	/	Unkown
HY-123396A	8-Chloro-cAMP sodium	Modulator	/	Unkown
HY-12366S	Ubrogepant-d5	Antagonist	/	Unkown
HY-124681	NY0116	Agonist	/	Unkown
HY-12525A	LGD-6972 sodium	Antagonist	/	Unkown
HY-125382	L-797591	Agonist	/	Unkown
HY-129474	MP 518	Inhibitor	/	Unkown
HY-131421	8-PIP-cAMP	Activator	/	Unkown
HY-131664	EP3 antagonist 2	Antagonist	/	Unkown
HY-131764	2'-O-MB-cGMP sodium	Inhibitor	/	Unkown
HY-131766	2'-O-Me-cAMP	Activator	/	Unkown
HY-131777	2-Cl-cAMP	Agonist	/	Unkown
HY-131823	5,6-DCl-cBIMP	Agonist	/	Unkown
HY-131824	5,6-DM-cBIMP	Agonist	/	Unkown
HY-131842	6-Bn-cAMP	Activator	/	Unkown
HY-131844	6-Bnz-5'-AMP		/	Unkown
HY-134299	8-CPT-cAMP-AM	Activator	/	Unkown
HY-134302	8-HA-cAMP	Activator	/	Unkown
HY-134308	8-NBD-cAMP sodium		/	Unkown
HY-134325	8-OH-cAMP	Agonist	/	Unkown
HY-134332	8-pCPT-5'-AMP	Activator	/	Unkown
HY-134348	8-pHPT-2'-O-Me-cAMP	Agonist	/	Unkown
HY-134389	6-Phe-cAMP	Activator	/	Unkown
HY-134406	6-Cl-cPuMP sodium	Modulator	/	Unkown
HY-137381	6-Bnz-cAMP		/	Unkown
HY-13749S3	Sitagliptin-d6	Inhibitor	/	Unkown
HY-137530	8-MA-cAMP	Agonist	/	Unkown
HY-137624	Sp-cAMPS-AM	Activator	/	Unkown
HY-137628	Sp-8-PIP cAMP	Agonist	/	Unkown
HY-137630	Sp-8-pCPT-2'-O-Me-cAMPS	Activator	/	Unkown
HY-137632	Sp-8-Cl-cAMPS		/	Unkown
HY-137635	Sp-6-Phe-cAMPS	Activator	/	Unkown
HY-137640	Sp-8-Br-cAMPS	Agonist	/	Unkown
HY-137641	Sp-8-Br-2'-O-Me-cAMPS	Activator	/	Unkown
HY-145457	RS-23597	Antagonist	/	Unkown
HY-148596	UDP-GlcNAc		/	Unkown
HY-155940	8-(4-Chlorophenylthio)-cAMP	Activator	/	Unkown
HY-156925	PKA/AKAP-IN-1	Inhibitor	/	Unkown
HY-157010	AP736	Inhibitor	/	Unkown
HY-165553	ASB16165	Inhibitor	/	Unkown
HY-165568	OPC 3911		/	Unkown
HY-167284	Bromoacetylalprenololmenthane	Antagonist	/	Unkown
HY-170970	Mtb-IN-10	Inhibitor	/	Unkown
HY-172411	GLP-1R agonist 29	Agonist	/	Unkown
HY-179376	Anti-virulence factor-IN-3	Inhibitor	/	Unkown
HY-179518	Antifungal agent 140	Inhibitor	/	Unkown
HY-180220	GLP-1R agonist 40	Agonist	/	Unkown
HY-180845	TGR5 agonist 9	Agonist	/	Unkown
HY-181102	TGR5 agonist 10	Agonist	/	Unkown
HY-181485	GPR68 antagonist 1		/	Unkown
HY-183180	CGRP antagonist-8	Antagonist	/	Unkown
HY-183181	CGRP antagonist-9	Antagonist	/	Unkown
HY-183400	BIM-46174		/	Unkown
HY-183455	CI-930	Inhibitor	/	Unkown
HY-183945	WO-459	Agonist	/	Unkown
HY-184849	Glu-Arg		/	Unkown
HY-184966	GIPR antagonist 4	Agonist	/	Unkown
HY-19436S	Solabegron-d8	Agonist	/	Unkown
HY-29268	β-Carboline-1-carboxylic acid	Inhibitor	/	Unkown
HY-47412	Cariprazine impurity 1	Agonist	99.74%	Unkown
HY-48289	PKA/AKAP-IN-2	Inhibitor	/	Unkown
HY-B0377A	Famotidine hydrochloride		/	Unkown
HY-B0377S1	Famotidine-13C		/	Unkown
HY-B0679S	Lubiprostone-d7		/	Unkown
HY-B0764G	Bucladesine sodium (GMP)	Activator	/	Unkown
HY-B1505A	Acefylline piperazine		/	Unkown
HY-N14662	Griseolic acid B	Inhibitor	/	Unkown
HY-N7648	Atherosperminine	Inhibitor	/	Unkown
HY-N7648A	Atherosperminine hydrochloride	Inhibitor	/	Unkown
HY-P0036S2	Octreotide-d8		/	Unkown
HY-P0036S3	Octreotide-13C9,15N		/	Unkown
HY-P0036S4	Octreotide-d8 acetate		/	Unkown
HY-RS22909	Vamp5 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS23258	Camp Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W011683S7	2'-Deoxyadenosine monohydrate-15N5		/	Unkown
HY-W097929	Tyrene	Inhibitor	≥97.0%	Unkown
HY-W394717	BGC-20-1531		/	Unkown
HY-W436495	6,15-Diketo-13,14-dihydro prostaglandin F1α		/	Unkown
HY-W778207	2'-Deoxyadenosine-13C5 monohydrate		/	Unkown
HY-P0036S	Octreotide-d8 TFA		/	Unkown
HY-U00341	ST4206	Antagonist	/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P991202	Anti-TSHR Antibody (M22)		99.46%	Unkown

Orthologs Information

Species	Symbol	Source	ID
Felis catus	CAMP	VGNC	VGNC:60340
Mus musculus	CAMP	MGD	MGI:108443
Canis familiaris	CAMP	VGNC	VGNC:38688
Macaca mulatta	CAMP	VGNC	VGNC:84221
Rattus norvegicus	CAMP	RGD	RGD:1559878
Others	CAMP	NCBI